Table 2.
Antimalarial treatments for children with uncomplicated malaria according to bodyweight in four districts in Zambia
|
Bodyweight <10 kg
|
Bodyweight ≥10 kg
|
Total
|
||||
|---|---|---|---|---|---|---|
| Health facilities | No (%) | 95% CI | No (%) | 95% CI | No (%) | 95% CI |
| All facilities:
|
n=550
|
n=394
|
n=944
|
|||
| Sulfadoxine-pyrimethamine | 439 (79.8) | 73.8 to 85.9 | 266 (67.5) | 58.8 to 76.2 | 705 (74.7) | 68.4 to 81.0 |
| Artemether-lumefantrine | 6 (1.1) | 0 to 2.6 | 42 (10.7) | 5.4 to 16.0 | 48 (5.1) | 2.6 to 7.5 |
| Quinine | 14 (2.6) | 0.8 to 4.3 | 19 (4.8) | 2.0 to 7.6 | 33 (3.5) | 1.8 to 5.2 |
| Chloroquine | 1 (0.2) | 0 to 0.5 | 0 | NA | 1 (0.1) | 0 to 0.3 |
| No antimalarial prescribed | 90 (16.4) | 10.7 to 22.0 | 67 (17.0) | 11.7 to 22.3 | 157 (16.6) | 11.9 to 21.4 |
|
Facilities with artemether-lumefantrine in stock:
|
n=262
|
n=192
|
n=454
|
|||
| Sulfadoxine-pyrimethamine | 189 (72.1) | 61.1 to 83.1 | 103 (53.7) | 39.7 to 67.6 | 292 (64.3) | 53.2 to 75.4 |
| Artemether-lumefantrine | 6 (2.3) | 0 to 5.7 | 42 (21.9) | 12.4 to 31.3 | 48 (10.6) | 6.1 to 15.1 |
| Quinine | 9 (3.4) | 0.3 to 6.6 | 6 (3.1) | 0.4 to 5.9 | 15 (3.3) | 1.0 to 5.6 |
| No antimalarial prescribed | 58 (22.1) | 11.8 to 32.5 | 41 (21.4) | 12.7 to 30.0 | 99 (21.8) | 13.0 to 30.6 |